CANCER OF THE HEAD & NECK--EPIDEMIOLOGY AND BIOCHEMISTRY
CANCER OF THE HEAD & NECK--EPIDEMIOLOGY AND BIOCHEMISTRY
批准号:
3177913
负责人:
JANET L BRANDSMA
金额:
$13.04万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-04-01 至 1988-03-31
关键词:
Epstein Barr virus Herpesviridae disease Papillomavirus adenocarcinoma biopsy cancer risk case history centrifugation esophagus neoplasm gel electrophoresis genetic manipulation head /neck neoplasm herpes simplex virus 1 human subject immunoperoxidase lymphoma molecular cloning mouth neoplasms nasopharyngeal neoplasms neoplasm /cancer genetics nucleic acid sequence oncogenes oncogenic virus oncoproteins oral pharyngeal neoplasm pharynx neoplasms salivary gland neoplasms serology /serodiagnosis squamous cell carcinoma viral carcinogenesis virus DNA virus RNA virus antigen virus diseases virus related neoplasm /cancer
中文摘要
人类癌症的诱导和发展过程是极其复杂的,
复杂的流行病学数据表明,
因素 肿瘤发生前数年病毒感染
可能是几个诱因之一。 细胞癌基因激活,
其次是遗传变异,是另一个被认为是重要的因素
在人类恶性肿瘤中。 本研究建议的具体目标是
检验病毒感染与以下风险增加有关的假设:
头部和颈部的癌症,并发现之间的关系
激活的癌基因和这些癌症。
调查将采用病例对照研究的形式。 研究
人群将由来自医生的约1200名患者组成,
朗大耳鼻喉科、外科、内科和牙科
岛犹太人山坡医疗中心。 病例(600例)将为
新诊断和治疗:口腔鳞状细胞癌
腔、口咽、鼻咽、下咽、喉、腺和鳞状
食管细胞癌,头颈部淋巴瘤,或
恶性涎腺肿瘤 对照组(600例)为患者
手术治疗相同部位的良性疾病。
既往感染的发生将通过:病史、血清学
以及对获得的组织进行生物化学分析以确定病毒的存在
DNA/RNA斑点杂交和原位杂交
与分子克隆的病毒DNA探针和病毒衣壳杂交,
冰冻切片免疫过氧化物酶抗体染色核抗原
和印迹。 如果新的人乳头瘤病毒相关序列
一旦确定,我们将尝试克隆病毒DNA分子。 存在
将通过RNA斑点印迹进行生化研究,
分子克隆癌基因的北方印迹和原位杂交
probes. 该项目的两个部分-寻找病毒和致癌基因
参与将同时进行。
如果得到资助,这将是第一个大规模的病例对照流行病学研究。
在生物化学水平上研究头颈部癌症,
提供客观证据,帮助评估病毒是否
病因学和/或已知的致癌基因。 从更广泛的意义上说,这
这些信息将有助于我们理解
人类病毒、致癌基因和癌症之间的联系。
英文摘要
The process of induction and progression of human cancer is exceedingly
complex and epidemiologic data suggest the involvement of a multitude of
factors. Viral infection years prior to the development of the neoplasm
may be one of several precipitating factors. Cellular oncogene activation,
secondary to genetic alteration, is another factor believed to be important
in human malignancies. The specific aims of this research proposal are to
test the hypothesis that viral infection is related to an increased risk of
cancer(s) of the head and neck, and to discover the relationship between
activated oncogenes and these same cancers.
The investigation will take the form of a case-control study. The study
population will consist of approximately 1200 patients from physicians in
the Departments of Otolaryngology, Surgery, Medicine and Dentistry at Long
Island Jewish-Hillside Medical Center. Cases (600) will be patients who
are newly diagnosed and treated for: squamous cell carcinomas of the oral
cavity, oropharynx, nasopharynx, hypopharynx, larynx, adeno and squamous
cell carcinomas of the esophagus, lymphomas of the head and neck, or
malignant salivary gland tumors. Controls (600) will be patients
surgically treated for benign diseases of the same sites.
The occurrence of past infection will be ascertained by: history, serology
and biochemical analysis of tissues obtained for the presence of the viral
genome and RNA transcripts by Southern blots, DNA/RNA dot blot and in situ
hybridizations to molecularly cloned viral DNA probes, and viral capsid and
nuclear antigens by immunoperoxidase antibody staining of frozen sections
and impression smears. If novel human papillomavirus-related sequences are
identified, we will attempt to clone the viral DNA molecule. The presence
of activated oncogenes will be studied biochemically by RNA dot blot,
Northern blot and in situ hybridizations to molecularly cloned oncogene
probes. The two sections of the project - looking for viral and oncogene
involvement will be done concurrently.
If funded, this would be the first large-scale case-control epidemiologic
study of cancers of the head and neck at the biochemical level and would
provide objective evidence which should help in evaluating whether a viral
etiology and/or known oncogenes are involved. In a broader sense, this
information will contribute to our understanding of the interactions
between human viruses and oncogenes and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Langerhans cell-mediated immune modulation of HPV8 expression and tumorgenesis
-
批准号:7530393
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2008
-
负责人:JANET L BRANDSMA
-
依托单位:
Langerhans cell-mediated immune modulation of HPV8 expression and tumorgenesis
-
批准号:7624197
-
项目类别:
-
资助金额:$22.34万
-
财政年份:2008
-
负责人:JANET L BRANDSMA
-
依托单位:
Papillomavirus E2 as a cervical/anal cancer drug target
-
批准号:6915013
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2004
-
负责人:JANET L BRANDSMA
-
依托单位:
Papillomavirus E2 as a cervical/anal cancer drug target
-
批准号:6844396
-
项目类别:
-
资助金额:$23.39万
-
财政年份:2004
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:6679199
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:6761813
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:7226737
-
项目类别:
-
资助金额:$31.04万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:7060357
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
VSV-based Therapeutic Papilloma Vaccine
-
批准号:6897543
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2003
-
负责人:JANET L BRANDSMA
-
依托单位:
CTL responses to vaccination in CRPV rabbit model
-
批准号:6445484
-
项目类别:
-
资助金额:$7.23万
-
财政年份:2001
-
负责人:JANET L BRANDSMA
-
依托单位:
GENETIC DETERMINANTS OF HUMAN PAPILLOMAVIRUS PATHOGENICITY
-
批准号:6268828
-
项目类别:
-
资助金额:$16.76万
-
财政年份:1998
-
负责人:JANET L BRANDSMA
-
依托单位:
GENETIC DETERMINANTS OF HUMAN PAPILLOMAVIRUS PATHOGENICITY
-
批准号:6236233
-
项目类别:
-
资助金额:$16.14万
-
财政年份:1997
-
负责人:JANET L BRANDSMA
-
依托单位:
PROTECTIVE AND THERAPEUTIC IMMUNITY TO PAPILLOMATOSIS
-
批准号:3202259
-
项目类别:
-
资助金额:$28.83万
-
财政年份:1992
-
负责人:JANET L BRANDSMA
-
依托单位:
PROTECTIVE AND THERAPEUTIC IMMUNITY TO PAPILLOMATOSIS
-
批准号:2098672
-
项目类别:
-
资助金额:$29.38万
-
财政年份:1992
-
负责人:JANET L BRANDSMA
-
依托单位:
PROTECTIVE AND THERAPEUTIC IMMUNITY TO PAPILLOMATOSIS
-
批准号:2098673
-
项目类别:
-
资助金额:$31.34万
-
财政年份:1992
-
负责人:JANET L BRANDSMA
-
依托单位:
CTL responses to vaccination in CRPV rabbit model
-
批准号:6318510
-
项目类别:
-
资助金额:$7.23万
-
财政年份:1992
-
负责人:JANET L BRANDSMA
-
依托单位:
PROTECTIVE AND THERAPEUTIC IMMUNITY TO PAPILLOMATOSIS
-
批准号:3202258
-
项目类别:
-
资助金额:$28.99万
-
财政年份:1992
-
负责人:JANET L BRANDSMA
-
依托单位:
STUDIES IN VIVO OF PAPILLOMAVIRUS TRANSFORMING GENES
-
批准号:3423644
-
项目类别:
-
资助金额:$8.4万
-
财政年份:1991
-
负责人:JANET L BRANDSMA
-
依托单位:
VIVO OF PAPILLOMAVIRUS TRANSFORMING GENES
-
批准号:3423645
-
项目类别:
-
资助金额:$8.2万
-
财政年份:1991
-
负责人:JANET L BRANDSMA
-
依托单位:
CANCER OF THE HEAD & NECK--EPIDEMIOLOGY AND BIOCHEMISTRY
-
批准号:3177914
-
项目类别:
-
资助金额:$14.02万
-
财政年份:1985
-
负责人:JANET L BRANDSMA
-
依托单位: